{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:10:09Z","timestamp":1788246609874,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.abd.2020.10.007","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T07:53:13Z","timestamp":1627026793000},"page":"581-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-5261","authenticated-orcid":false,"given":"Patr\u00edcia Penha Silveira","family":"Fagundes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-4254","authenticated-orcid":false,"given":"Claudia Giuli","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-5526","authenticated-orcid":false,"given":"Celina Wakisaka","family":"Maruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-4475","authenticated-orcid":false,"given":"Denise","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-4413","authenticated-orcid":false,"given":"Valeria","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2020.10.007_bib0005","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI28547","article-title":"T cell control in autoimmune bullous skin disorders","volume":"116","author":"Hertl","year":"2006","journal-title":"J Clin Invest."},{"key":"10.1016\/j.abd.2020.10.007_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2005.12.012","article-title":"The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients","volume":"54","author":"Ambros-Rudolph","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.det.2011.06.008","article-title":"Management of autoimmune blistering diseases in pregnancy","volume":"29","author":"McPherson","year":"2011","journal-title":"Dermatol Clin."},{"key":"10.1016\/j.abd.2020.10.007_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2230.1999.00472.x","article-title":"Clinical features and management of 87 patients with pemphigoid gestationis","volume":"24","author":"Jenkins","year":"1999","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.abd.2020.10.007_bib0030","doi-asserted-by":"crossref","first-page":"A502","DOI":"10.1016\/j.autrev.2011.12.003","article-title":"Progesterone and autoimmune disease","volume":"11","author":"Hughes","year":"2012","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.abd.2020.10.007_bib0035","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am J Reprod Immunol."},{"key":"10.1016\/j.abd.2020.10.007_bib0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/cmi.2012.23","article-title":"The CXCL12\/CXCR4 axis is involved in the maintenance of Th2 bias at the maternal\/fetal interface in early human pregnancy","volume":"9","author":"Piao","year":"2012","journal-title":"Cell Mol Immunol."},{"key":"10.1016\/j.abd.2020.10.007_bib0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/sji.12453","article-title":"New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy","volume":"84","author":"Tavakolpour","year":"2016","journal-title":"Scand J Immunol."},{"key":"10.1016\/j.abd.2020.10.007_bib0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/dth.12076","article-title":"Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy","volume":"26","author":"Braunstein","year":"2013","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.abd.2020.10.007_bib0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-4632.2006.03044.x","article-title":"Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients","volume":"46","author":"Michailidou","year":"2007","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0060","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OGX.0b013e3181bea089","article-title":"Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes","volume":"64","author":"Kardos","year":"2009","journal-title":"Obstet Gynecol Surv."},{"key":"10.1016\/j.abd.2020.10.007_bib0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2133.2002.04969.x","article-title":"Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris","volume":"147","author":"Campo-Voegeli","year":"2002","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0190-9622(93)70123-B","article-title":"Pemphigus vulgaris and pregnancy: risk factors and recommendations","volume":"28","author":"Goldberg","year":"1993","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.144.6.783","article-title":"Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy?","volume":"144","author":"Lehman","year":"2008","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/1346-8138.12675","article-title":"Cooperative Group on Fogo Selvagem R. Update on fogo selvagem, an endemic form of pemphigus foliaceus","volume":"42","author":"Aoki","year":"2015","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.1993.01680220081019","article-title":"Pemphigus foliaceus in young women. An endemic focus in the Sousse area of Tunisia","volume":"129","author":"Morini","year":"1993","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/archderm.1995.01690230088014","article-title":"Neonatal pemphigus foliaceus","volume":"131","author":"Walker","year":"1995","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM200007063430105","article-title":"Protection against pemphigus foliaceus by desmoglein 3 in neonates","volume":"343","author":"Wu","year":"2000","journal-title":"N Engl J Med."},{"key":"10.1016\/j.abd.2020.10.007_bib0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/1523-1747.ep12611868","article-title":"Pregnant women with endemic pemphigus foliaceus (Fogo Selvagem) give birth to disease-free babies","volume":"99","author":"Rocha-Alvarez","year":"1992","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.2011.10346.x","article-title":"The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy","volume":"165","author":"Buijsrogge","year":"2011","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2340\/00015555-1065","article-title":"Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases","volume":"91","author":"Kim","year":"2011","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2020.10.007_bib0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2340\/00015555-2557","article-title":"Linear IgA Bullous Dermatosis in a Pregnant Woman with Autoantibodies to the Non-collagenous 16A Domain of Type XVII Collagen","volume":"97","author":"Matsuura","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2020.10.007_bib0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2133.1989.tb01371.x","article-title":"Immunopathology of the placenta in pemphigoid gestationis and linear IgA disease","volume":"120","author":"Kelly","year":"1989","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0190-9622(94)70047-8","article-title":"Linear IgA disease and pregnancy","volume":"30","author":"Collier","year":"1994","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1155\/2006\/470273","article-title":"Gluten intolerance: sex and age-related features","volume":"20","author":"Llorente-Alonso","year":"2006","journal-title":"Can J Gastroenterol."},{"key":"10.1016\/j.abd.2020.10.007_bib0135","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/014107688908200724","article-title":"Linear IgA disease in association with hydatidiform mole","volume":"82","author":"Kelly","year":"1989","journal-title":"J R Soc Med."},{"key":"10.1016\/j.abd.2020.10.007_bib0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archdermatol.2010.317","article-title":"Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant","volume":"147","author":"Abrams","year":"2011","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2340\/0001555563353356","article-title":"Pregnancy as a trigger of epidermolysis bullosa acquisita","volume":"63","author":"Kero","year":"1983","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2020.10.007_bib0150","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(97)80352-0","article-title":"Epidermolysis bullosa acquisita exacerbated by systemic estrogen and progesterone treatment and pregnancy","volume":"36","author":"Kubo","year":"1997","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0155","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archderm.1982.01650230004004","article-title":"Successful pregnancy in a patient with dermatitis herpetiformis treated with low-dose dapsone","volume":"118","author":"Tuffanelli","year":"1982","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000457034","article-title":"Clinical pharmacokinetics in pregnancy and perinatology. I. Placental transfer and fetal side effects of local anaesthetic agents","volume":"8","author":"Nau","year":"1985","journal-title":"Dev Pharmacol Ther."},{"key":"10.1016\/j.abd.2020.10.007_bib0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.abd.2020.10.007_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijwd.2015.12.005","article-title":"Understanding the new FDA pregnancy and lactation labeling rules","volume":"2","author":"Blattner","year":"2016","journal-title":"Int J Womens Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40257-018-0342-0","article-title":"Treatment of Autoimmune Bullous Disorders in Pregnancy","volume":"19","author":"Kushner","year":"2018","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ."},{"key":"10.1016\/j.abd.2020.10.007_bib0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/icb.1981.66","article-title":"Changes in the concentration of cortisol in milk during different stages of human lactation","volume":"59","author":"Kulski","year":"1981","journal-title":"Aust J Exp Biol Med Sci."},{"key":"10.1016\/j.abd.2020.10.007_bib0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2013.09.009","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation","volume":"70","author":"Butler","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0195","first-page":"684","article-title":"Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double-blind, placebo-controlled clinical trial","volume":"9","author":"Iraji","year":"2010","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12641","article-title":"Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration","volume":"59","author":"Rademaker","year":"2018","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0210","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1097\/MIB.0000000000000923","article-title":"Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease","volume":"22","author":"Mottet","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.abd.2020.10.007_bib0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"Ostensen","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.abd.2020.10.007_bib0220","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.clindermatol.2016.02.006","article-title":"Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum","volume":"34","author":"Wan","year":"2016","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0036-1597933","article-title":"What Is the Teratogenic Risk of Mycophenolate?","volume":"6","author":"Kylat","year":"2017","journal-title":"J Pediatr Genet."},{"key":"10.1016\/j.abd.2020.10.007_bib0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/03602539509029818","article-title":"Dapsone-induced hemolytic anemia","volume":"27","author":"Jollow","year":"1995","journal-title":"Drug Metab Rev."},{"key":"10.1016\/j.abd.2020.10.007_bib0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjd.13729","volume":"173","author":"Chalmers","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2020.10.007_bib0240","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood-time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expert Opin Drug Saf."},{"key":"10.1016\/j.abd.2020.10.007_bib0245","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.abd.2020.10.007_bib0250","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059621001707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059621001707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:39:29Z","timestamp":1759793969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059621001707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0365059621001707"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2020.10.007","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2020.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Dermatologia.","name":"copyright","label":"Copyright"}]}}